Skip to main content
. Author manuscript; available in PMC: 2021 Apr 24.
Published in final edited form as: J Aging Phys Act. 2020 Apr 24;28(2):306–310. doi: 10.1123/japa.2018-0462

Table 2.

Mobility activity according to VTE prophylaxis use.

Activity Variables Pharm VTE PPX used (n = 40) No Pharm VTE PPX used (n=25) Wilcoxon
p-value
Total time in activity (hours/day) 1.0 (0.6, 1.5) 1.2 (0.7, 1.8) 0.2
Total time sedentary (hours/day) 14.8 (12.4, 17.1) 14.4 (11.1, 16.9) 0.4
Total steps (steps/day) 1320 (764, 2135) 1809 (1126, 3207) 0.1

Values represent median (interquartile range). PPX = prophylaxis, VTE = venous thromboembolism